We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$439M
AUM Growth
-$24.1M
Cap. Flow
-$11.5M
Cap. Flow %
-2.61%
Top 10 Hldgs %
16.89%
Holding
302
New
33
Increased
60
Reduced
85
Closed
40

Sector Composition

Rank Sector Weight
1 Industrials 16.39%
2 Technology 15.57%
3 Healthcare 13.35%
4 Materials 8.65%
5 Financials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRA
26
DELISTED
W.R. Grace & Co.
GRA
$4.62M 1.05%
75,385
-3,207
-4% -$220K
HOLX
27
DELISTED
Hologic
HOLX
$4.51M 1.03%
120,614
-5,118
-4% -$207K
BALL icon
28
Ball Corp
BALL
$17B
$4.46M 1.02%
112,349
-4,953
-4% -$194K
FUL icon
29
H.B. Fuller
FUL
$3B
$4.45M 1.01%
89,489
-2,014
-2% -$104K
FSS icon
30
Federal Signal
FSS
$7.25B
$4.28M 0.98%
194,432
-7,833
-4% -$162K
LECO icon
31
Lincoln Electric
LECO
$13.8B
$4.23M 0.96%
+46,979
New +$4.38M
BERY
32
DELISTED
Berry Global Group, Inc.
BERY
$4.18M 0.95%
83,036
-3,990
-5% -$208K
FBIN icon
33
Fortune Brands Innovations
FBIN
$6.12B
$3.88M 0.88%
77,179
-4,416
-5% -$246K
CRS icon
34
Carpenter Technology
CRS
$30B
$3.75M 0.85%
84,963
-3,245
-4% -$163K
CSCO icon
35
Cisco
CSCO
$450B
$3.45M 0.79%
80,405
-7,297
-8% -$309K
PFE icon
36
Pfizer
PFE
$140B
$3.41M 0.78%
101,195
-3,156
-3% -$108K
IBM icon
37
IBM
IBM
$202B
$3.02M 0.69%
20,595
+15,843
+333% +$2.4M
AKBA icon
38
Akebia Therapeutics
AKBA
$327M
$3M 0.68%
+314,401
New +$4.4M
INTC icon
39
Intel
INTC
$466B
$2.78M 0.63%
53,412
-734
-1% -$34.9K
CNA icon
40
CNA Financial
CNA
$14.5B
$2.77M 0.63%
56,020
-1,213
-2% -$63.4K
PX
41
DELISTED
Praxair Inc
PX
$2.76M 0.63%
19,102
+14,325
+300% +$2.23M
VZ icon
42
Verizon
VZ
$194B
$2.71M 0.62%
56,761
-2,989
-5% -$150K
TFC icon
43
Truist Financial
TFC
$63.2B
$2.63M 0.6%
50,570
-5,562
-10% -$300K
EXC icon
44
Exelon
EXC
$48.6B
$2.59M 0.59%
93,103
-5,760
-6% -$156K
WMT icon
45
Walmart Inc
WMT
$871B
$2.55M 0.58%
86,070
-7,758
-8% -$250K
GILD icon
46
Gilead Sciences
GILD
$161B
$2.43M 0.55%
32,268
-2,633
-8% -$209K
SLB icon
47
SLB Ltd
SLB
$77.8B
$2.3M 0.52%
+35,551
New +$2.48M
MO icon
48
Altria Group
MO
$122B
$2.29M 0.52%
36,673
-3,304
-8% -$219K
CME icon
49
CME Group
CME
$92.2B
$2.26M 0.51%
13,957
-716
-5% -$114K
BA icon
50
Boeing
BA
$165B
$2.25M 0.51%
6,872
-1,837
-21% -$621K

Similar funds

Stanley-Laman Group's Q1 2018 Portfolio in Review

As of Q1 2018, Stanley-Laman Group held 302 positions worth $439M, down 5.2% from $463M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stanley-Laman Group's Q1 2018 filing shows 33 new, 60 increased, 85 reduced and 40 closed positions. Its largest new stake was Rockwell Automation: 37,619 shares worth $6.55M. The largest sale was Acadia Pharmaceuticals, an estimated $7.95M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

  • Stanley-Laman Group's largest Q1 2018 buy was Rockwell Automation: 37,619 shares worth $6.55M.
  • Stanley-Laman Group added most to Hortonworks, Inc. in Q1 2018, an estimated $8.35M increase.
  • Stanley-Laman Group's biggest Q1 2018 reduction was Acadia Pharmaceuticals, cutting an estimated $7.95M.
  • Stanley-Laman Group fully exited Palo Alto Networks in Q1 2018, selling an estimated $7.12M.
  • Stanley-Laman Group's ten largest holdings make up 17% of its $439M portfolio in Q1 2018.
  • Stanley-Laman Group opened 33 new positions and closed 40 in Q1 2018.
  • Stanley-Laman Group's portfolio value fell 5.2% quarter-over-quarter to $439M.

Based on Stanley-Laman Group's 13F filing for Q1 2018, filed 1 May 2018.